1. Home
  2. LSTA vs SFHG Comparison

LSTA vs SFHG Comparison

Compare LSTA & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • SFHG
  • Stock Information
  • Founded
  • LSTA 1980
  • SFHG 1993
  • Country
  • LSTA United States
  • SFHG Hong Kong
  • Employees
  • LSTA N/A
  • SFHG N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • SFHG Publishing
  • Sector
  • LSTA Health Care
  • SFHG Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • LSTA 22.5M
  • SFHG 18.9M
  • IPO Year
  • LSTA N/A
  • SFHG 2024
  • Fundamental
  • Price
  • LSTA $2.69
  • SFHG $0.81
  • Analyst Decision
  • LSTA Strong Buy
  • SFHG
  • Analyst Count
  • LSTA 2
  • SFHG 0
  • Target Price
  • LSTA $23.50
  • SFHG N/A
  • AVG Volume (30 Days)
  • LSTA 56.3K
  • SFHG 61.3K
  • Earning Date
  • LSTA 08-11-2025
  • SFHG 07-29-2025
  • Dividend Yield
  • LSTA N/A
  • SFHG N/A
  • EPS Growth
  • LSTA N/A
  • SFHG N/A
  • EPS
  • LSTA N/A
  • SFHG N/A
  • Revenue
  • LSTA $1,000,000.00
  • SFHG $19,760,935.00
  • Revenue This Year
  • LSTA N/A
  • SFHG N/A
  • Revenue Next Year
  • LSTA N/A
  • SFHG N/A
  • P/E Ratio
  • LSTA N/A
  • SFHG N/A
  • Revenue Growth
  • LSTA N/A
  • SFHG 30.89
  • 52 Week Low
  • LSTA $1.87
  • SFHG $0.55
  • 52 Week High
  • LSTA $4.20
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 52.66
  • SFHG N/A
  • Support Level
  • LSTA $2.45
  • SFHG N/A
  • Resistance Level
  • LSTA $2.74
  • SFHG N/A
  • Average True Range (ATR)
  • LSTA 0.27
  • SFHG 0.00
  • MACD
  • LSTA -0.00
  • SFHG 0.00
  • Stochastic Oscillator
  • LSTA 51.81
  • SFHG 0.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: